ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Dosdogs
|
23K |
11M |
48 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
23K
|
11M
|
48
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 onCARlytics Trial Advances to Combination Arm
|
|
Dosdogs
|
147 |
63K |
3 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
147
|
63K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 onCARlytics Trial Advances to Combination Arm
|
|
Dosdogs
|
147 |
63K |
7 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
147
|
63K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Dosdogs
|
23K |
11M |
46 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
23K
|
11M
|
46
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA Fast Track Designation Granted for VAXINIA Trial Program
|
|
Dosdogs
|
412 |
170K |
23 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
412
|
170K
|
23
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Dosdogs
|
23K |
11M |
19 |
26/11/23 |
26/11/23 |
ASX - By Stock
|
23K
|
11M
|
19
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The CF33, Vaxinia and Oncarlytics Deal
|
|
Dosdogs
|
1.0K |
633K |
28 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
1.0K
|
633K
|
28
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The CF33, Vaxinia and Oncarlytics Deal
|
|
Dosdogs
|
1.0K |
633K |
57 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
1.0K
|
633K
|
57
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33 VAXINIA Study Update - Positive Early Signals
|
|
Dosdogs
|
315 |
144K |
35 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
315
|
144K
|
35
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Dosdogs
|
31K |
15M |
22 |
24/10/23 |
24/10/23 |
Charts
|
31K
|
15M
|
22
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene B Cell & OV Platforms Featured at ESMO Congress
|
|
Dosdogs
|
188 |
77K |
29 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
188
|
77K
|
29
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Dosdogs
|
13K |
6.3M |
23 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
13K
|
6.3M
|
23
|
|
ASX - By Stock
|
RCE |
Re:
Need to push the IV dose higher
|
|
Dosdogs
|
26 |
10K |
4 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
26
|
10K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Licenses Allogeneic CD19 CAR T Cell Therapy
|
|
Dosdogs
|
479 |
207K |
38 |
20/08/23 |
20/08/23 |
ASX - By Stock
|
479
|
207K
|
38
|
|
ASX - By Stock
|
IMU |
Re:
City of Hope cancer treatment
|
|
Dosdogs
|
47 |
24K |
21 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
47
|
24K
|
21
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Dosdogs
|
23K |
11M |
30 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
23K
|
11M
|
30
|
|
ASX - By Stock
|
RCE |
Re:
Ann: First Cohort Dosed in Rapid Infusion Phase I/II UTI study
|
|
Dosdogs
|
22 |
7.4K |
1 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
22
|
7.4K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: New Dose Escalation in Phase I Clinical Trial of CHECKvacc
|
|
Dosdogs
|
96 |
43K |
12 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
96
|
43K
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Ann: New Dose Escalation in Phase I Clinical Trial of CHECKvacc
|
|
Dosdogs
|
96 |
43K |
28 |
09/07/23 |
09/07/23 |
ASX - By Stock
|
96
|
43K
|
28
|
|
ASX - By Stock
|
IMU |
Re:
Ann: HER-Vaxx induced antibodies correlated with tumour reduction
|
|
Dosdogs
|
156 |
72K |
1 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
156
|
72K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: HER-Vaxx induced antibodies correlated with tumour reduction
|
|
Dosdogs
|
156 |
72K |
4 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
156
|
72K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: HER-Vaxx induced antibodies correlated with tumour reduction
|
|
Dosdogs
|
156 |
72K |
5 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
156
|
72K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Dosdogs
|
23K |
11M |
40 |
20/03/23 |
20/03/23 |
ASX - By Stock
|
23K
|
11M
|
40
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Dosdogs
|
23K |
11M |
4 |
23/01/23 |
23/01/23 |
ASX - By Stock
|
23K
|
11M
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: HER-Vaxx and CF33 Platforms Featured at ASCO Symposium
|
|
Dosdogs
|
53 |
33K |
2 |
22/01/23 |
22/01/23 |
ASX - By Stock
|
53
|
33K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Competitive landscape
|
|
Dosdogs
|
244 |
114K |
0 |
22/01/23 |
22/01/23 |
ASX - By Stock
|
244
|
114K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Competitive landscape
|
|
Dosdogs
|
244 |
114K |
0 |
22/01/23 |
22/01/23 |
ASX - By Stock
|
244
|
114K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: HER-Vaxx and CF33 Platforms Featured at ASCO Symposium
|
|
Dosdogs
|
53 |
33K |
3 |
22/01/23 |
22/01/23 |
ASX - By Stock
|
53
|
33K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: HER-Vaxx and CF33 Platforms Featured at ASCO Symposium
|
|
Dosdogs
|
53 |
33K |
1 |
21/01/23 |
21/01/23 |
ASX - By Stock
|
53
|
33K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: HER-Vaxx and CF33 Platforms Featured at ASCO Symposium
|
|
Dosdogs
|
53 |
33K |
0 |
21/01/23 |
21/01/23 |
ASX - By Stock
|
53
|
33K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: HER-Vaxx and CF33 Platforms Featured at ASCO Symposium
|
|
Dosdogs
|
53 |
33K |
3 |
21/01/23 |
21/01/23 |
ASX - By Stock
|
53
|
33K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Dosdogs
|
13K |
6.3M |
5 |
14/12/22 |
14/12/22 |
ASX - By Stock
|
13K
|
6.3M
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Ann: CHECKVacc Data Presented at the 2022 SABC Symposium
|
|
Dosdogs
|
134 |
62K |
25 |
09/12/22 |
09/12/22 |
ASX - By Stock
|
134
|
62K
|
25
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Dosdogs
|
13K |
6.3M |
10 |
07/12/22 |
07/12/22 |
ASX - By Stock
|
13K
|
6.3M
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Positive New HER-Vaxx HERIZON Data Presented at ESMO Asia
|
|
Dosdogs
|
71 |
38K |
11 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
71
|
38K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene onCARlytics with Estrella ARTEMIS T Cells SITC
|
|
Dosdogs
|
79 |
47K |
13 |
16/11/22 |
16/11/22 |
ASX - By Stock
|
79
|
47K
|
13
|
|
ASX - By Stock
|
RCE |
Re:
Need to push the IV dose higher
|
|
Dosdogs
|
26 |
10K |
4 |
19/10/22 |
19/10/22 |
ASX - By Stock
|
26
|
10K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Dosdogs
|
13K |
6.3M |
4 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
13K
|
6.3M
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Safety Data from Phase 1 Clinical Trial
|
|
Dosdogs
|
120 |
37K |
8 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
120
|
37K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Dosdogs
|
13K |
6.3M |
9 |
01/01/22 |
01/01/22 |
ASX - By Stock
|
13K
|
6.3M
|
9
|
|
ASX - By Stock
|
TLX |
Re:
Ann: FDA Approves Telix Prostate Cancer Imaging Product Illuccix
|
|
Dosdogs
|
42 |
16K |
9 |
20/12/21 |
20/12/21 |
ASX - By Stock
|
42
|
16K
|
9
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Patients to be Dosed in Ph 1 IV Clinical Trial of R327
|
|
Dosdogs
|
37 |
11K |
8 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
37
|
11K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA IND APPROVAL FOR THE PHASE 2 CLINICAL TRIAL OF HER-VAXX
|
|
Dosdogs
|
167 |
87K |
2 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
167
|
87K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA IND APPROVAL FOR THE PHASE 2 CLINICAL TRIAL OF HER-VAXX
|
|
Dosdogs
|
167 |
87K |
4 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
167
|
87K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA IND APPROVAL FOR THE PHASE 2 CLINICAL TRIAL OF HER-VAXX
|
|
Dosdogs
|
167 |
87K |
3 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
167
|
87K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA IND APPROVAL FOR THE PHASE 2 CLINICAL TRIAL OF HER-VAXX
|
|
Dosdogs
|
167 |
87K |
1 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
167
|
87K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA IND APPROVAL FOR THE PHASE 2 CLINICAL TRIAL OF HER-VAXX
|
|
Dosdogs
|
167 |
87K |
0 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
167
|
87K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA IND APPROVAL FOR THE PHASE 2 CLINICAL TRIAL OF HER-VAXX
|
|
Dosdogs
|
167 |
87K |
1 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
167
|
87K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA IND APPROVAL FOR THE PHASE 2 CLINICAL TRIAL OF HER-VAXX
|
|
Dosdogs
|
167 |
87K |
1 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
167
|
87K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA IND APPROVAL FOR THE PHASE 2 CLINICAL TRIAL OF HER-VAXX
|
|
Dosdogs
|
167 |
87K |
2 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
167
|
87K
|
2
|
|